RSS Feed

Latest news

Envarsus: first tablet presentation of tacrolimus

Envarsus: first tablet presentation of tacrolimus

Chiesi has launched Envarsus, the first prolonged-release...

Ultra long-acting insulin approved for paediatric use

Ultra long-acting insulin approved for paediatric use

The once-daily basal insulin analogue Tresiba (insulin...

Otezla: new treatment for psoriasis and psoriatic arthritis

Otezla: new treatment for psoriasis and psoriatic arthritis

Celgene has launched Otezla (apremilast) for use in...

Remsima and Inflectra: new infliximab 'biosimilars'

Remsima and Inflectra: new infliximab 'biosimilars'

Remsima and Inflectra are the first biosimilar monoclonal...

NICE widens approval for TNF inhibitors in inflammatory bowel disease

NICE widens approval for TNF inhibitors in inflammatory bowel disease

NICE has broadened its guidance on the use of TNF-inhibiting...


New and deleted products

Promo Image

New Products

Products added to MIMS.

Promo Image

Deleted Products

Products removed from MIMS.


Most popular

Switching and Withdrawing Antidepressants

Quick-reference guide to switching and withdrawing...

H.pylori: Eradication Regimens (NICE)

Summary of NICE guidance for treatment of Helicobacter...

Summary of Antibiotic Treatments in Adults

Dose regimens for common bacterial infections.

Insulin Preparations

Quick-reference table for comparison of insulin profiles.

Topical Steroids, Comparison of Potencies and Formulations

Guide to strengths and preparations of topical steroids


Featured MIMS resources

Promo Image

Oral Iron Supplements for Iron-Deficiency States

Formulation, strength and dose information for oral iron supplements used in iron-deficiency states.

Promo Image

Lipid Modification for the Prevention of Cardiovascular Disease

A quick reference guide to the primary and secondary prevention of cardiovascular disease


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Cosentyx (secukinumab)

Hyabak UD (sodium hyaluronate)

Orphacol (cholic acid)

Pevanti (prednisolone)

Zevtera (ceftobiprole medocaril sodium)


Latest from MIMS Dermatology

New treatment for melasma

The hyperpigmentation disorder melasma can be distressing...

Comorbidities in patients with psoriasis

Patients with moderate to severe psoriasis are at increased...

Podiatry and diabetic foot ulcers

A US study investigated whether having podiatry before...


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.




Register for MIMS

Want to keep getting your free copy of MIMS? GPs will need to renew their subscription to keep receiving MIMS and GP for free in 2015. You can do this online now – take 2 minutes, and make sure you keep your free MIMS access!

Register

MIMS bulletins

News and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.